You have 8 free searches left this month | for more free features.

Macular edema secondary to retinal vein occlusion

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Anti-VEGF in Real-world

Recruiting
  • Neovascular Age-related Macular Edema
  • +5 more
  • Beijing, Beijing, China
    Wen-Bin Wei
Feb 2, 2022

Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Springfield,

Active, not recruiting
  • Age-Related Macular Degeneration
  • +4 more
  • bevacizumab
  • Springfield, Illinois
  • +2 more
Dec 6, 2021

Neovascular Age-related Macular Degeneration, Age-related Macular Degeneration, Diabetic Retinopathy Trial in Durham (AngioVue

Terminated
  • Neovascular Age-related Macular Degeneration
  • +4 more
  • AngioVue SD-OCT
  • Durham, North Carolina
    Duke Eye Center
Mar 29, 2022

Macular Edema, Retinal Vein Occlusion Trial in Damascus (suprachoroidal injection of Triamcinolone Acetonide.)

Completed
  • Macular Edema
  • Retinal Vein Occlusion
  • suprachoroidal injection of Triamcinolone Acetonide.
  • Damascus, Syrian Arab Republic
    Al Mouwasat University Hospital, Department of Ophthalmology
Aug 31, 2021

Central Retinal Vein Occlusion With Macular Edema Trial in Tanta (Ziv-Aflibercept 25 MG/ML [Zaltrap])

Completed
  • Central Retinal Vein Occlusion With Macular Edema
  • Ziv-Aflibercept 25 MG/ML [Zaltrap]
  • Tanta, El Gharbia, Egypt
    Tanta University
Oct 4, 2021

Diabetic Macular Edema, Vogt Koyanagi Harada Disease, Retinal Vein Occlusion Trial in Banha (Suprachoroidal triamcinolone

Recruiting
  • Diabetic Macular Edema
  • +2 more
  • Suprachoroidal triamcinolone acetonide injection
  • Banhā, Benha, Egypt
    Ahmed Abdelshafy Tabl
Aug 9, 2022

Collateral Damage From COVID-19 Pandemic Observed in Patients

Completed
  • Age Related Macular Degeneration
  • +2 more
  • Questionnaire
  • Data collection up to 1 year
  • Ecully, France
  • +3 more
Mar 2, 2022

Macular Edema, Central Retinal Vein Occlusion, Hemiretinal Vein Occlusion Trial in Worldwide (Faricimab, Aflibercept, Sham

Active, not recruiting
  • Macular Edema
  • +2 more
  • Mesa, Arizona
  • +193 more
Jul 25, 2022

Retinal Vein Occlusion, Macula Edema Trial in United States (TLC399 (ProDex))

Completed
  • Retinal Vein Occlusion
  • Macula Edema
  • TLC399 (ProDex)
  • Phoenix, Arizona
  • +19 more
Nov 24, 2021

Wet Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in United States (KSI-301)

Terminated
  • Wet Age-related Macular Degeneration
  • +2 more
  • Phoenix, Arizona
  • +10 more
Nov 1, 2022

Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Toronto (Intravitreal aflibercept)

Recruiting
  • Age Related Macular Degeneration
  • +3 more
  • Intravitreal aflibercept
  • Toronto, Ontario, Canada
  • +1 more
Apr 27, 2021

Age Related Macular Degeneration, Diabetic Macular Edema, Macular Edema Trial in Toronto (Intravitreal ranibizumab)

Recruiting
  • Age Related Macular Degeneration
  • +3 more
  • Intravitreal ranibizumab
  • Toronto, Ontario, Canada
  • +1 more
Apr 27, 2021

Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States

Completed
  • Age-related Macular Degeneration
  • +4 more
  • bevacizumab
  • Tucson, Arizona
  • +19 more
Nov 16, 2021

Macula Edema, Retinal Vein Occlusion Trial in Sydney (Ellex Integre NIR laser)

Recruiting
  • Macula Edema
  • Retinal Vein Occlusion
  • Ellex Integre NIR laser
  • Sydney, New South Wales, Australia
    Macular Research Group, Save Sight Institute, The University of
Apr 13, 2021

Branch Retinal Vein Occlusion With Macular Edema Trial in Stockholm (Aflibercept Injection [Eylea], Ranibizumab Injection

Recruiting
  • Branch Retinal Vein Occlusion With Macular Edema
  • Aflibercept Injection [Eylea]
  • Ranibizumab Injection [Lucentis]
  • Stockholm, Sweden
    St Eriks Eye Hospital
Dec 2, 2020

Central Retinal Vein Occlusion Trial in United States (aflibercept, bevacizumab)

Completed
  • Central Retinal Vein Occlusion
  • Phoenix, Arizona
  • +71 more
Jun 11, 2021

High Resolution Optical Coherence Tomography

Not yet recruiting
  • Retinal Disease
  • +15 more
  • High-resolution optical coherence tomography (High-Res-OCT)
  • Standard spectral domain OCT (SD-OCT)
  • Bern 3010, Bern, Switzerland
    Department of Ophthalmology, Bern University Hospital, Bern, 301
Nov 17, 2021

Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in Vienna (MacInfo presentation, Placebo

Recruiting
  • Age-related Macular Degeneration
  • +2 more
  • MacInfo presentation
  • Placebo presentation
  • Vienna, Austria
    Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch
Jan 24, 2022

Glaucoma, Glaucoma Suspect, Diabetic Retinopathy Trial in Philadelphia (Free Eye Screenings, Enhanced Intervention, Usual Care)

Completed
  • Glaucoma
  • +12 more
  • Free Eye Screenings
  • +2 more
  • Philadelphia, Pennsylvania
    Wills Eye Glaucoma Service
Aug 19, 2022

Macular Edema Secondary to Retinal Vein Occlusion Trial in Worldwide (Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose,

Not yet recruiting
  • Macular Edema Secondary to Retinal Vein Occlusion
  • Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose
  • +3 more
  • Fullerton, California
  • +311 more
Apr 28, 2023

Ophthalmopathy Trial in Asyut (Ranibizumab, triamcinolone acetate)

Unknown status
  • Ophthalmopathy
  • Asyut, Egypt
    Wael
Jul 2, 2020

Central Retinal Vein Occlusion With Macular Edema Trial in Germany (Ranibizumab Injection, Laser photocoagulation)

Recruiting
  • Central Retinal Vein Occlusion With Macular Edema
  • Ranibizumab Injection
  • Laser photocoagulation
  • Dresden, Germany
  • +13 more
May 5, 2022

Central Retinal Vein Occlusion Trial in Worldwide (Aflibercept (Eylea, BAY86-5321))

Completed
  • Central Retinal Vein Occlusion
  • Aflibercept (Eylea, BAY86-5321)
  • Albury, New South Wales, Australia
  • +41 more
Jun 19, 2020